EP3102198
ANTIDIABETIC COMPOUNDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.2.2015EP published:
26.8.2020EP application number:
15745823.3
EPO information:
European Patent Register
Max expiry date:
2.2.2035
Title:
ANTIDIABETIC COMPOUNDS
Timeline
Today
3.2.2015EP application
26.8.2020EP Publication
Owner
Name:
Merck Sharp & Dohme Corp.Address:
126 East Lincoln Avenue, Rahway, NJ 07065-0907, US
Inventor
Name:
CHOBANIAN, HarryAddress:
Kenilworth, NJ 07033, US
Name:
DEMONG, DuaneAddress:
Kenilworth, NJ 07033, US
Name:
GUO, YanAddress:
Kenilworth, NJ 07033, US
Name:
HU, ZhiyongAddress:
Kenilworth, NJ 07033, US
Name:
MILLER, MichaelAddress:
Kenilworth, NJ 07033, US
Name:
PIO, BarbaraAddress:
Kenilworth, NJ 07033, US
Name:
PLUMMER, Christopher, W.Address:
Kenilworth, NJ 07033, US
Name:
XIAO, DongAddress:
Kenilworth, NJ 07033, US
Name:
YANG, CangmingAddress:
Kenilworth, NJ 07033, US
Name:
ZHANG, RuiAddress:
Kenilworth, NJ 07033, US
Priority
Number:
201461936597 PDate:
6.2.2014Country:
US
Classification
Categories:
A61K 31/33, A61K 31/34, C07C 15/14